Dr. Vivek Gupta received his Ph.D. in pharmaceutical sciences from Texas Tech University Health Sciences Center, Amarillo, TX. He is currently an assistant professor of industrial pharmacy and pharmaceutics at St. John’s University in New York City. He has more than 10 years of experience in formulation design for novel drug delivery systems for non-invasive delivery of therapeutics, pharmacokinetic and pharmacodynamic characterization of delivery systems for enhanced lung accumulation and bioavailability. Dr. Vivek Gupta’s current research is focused on drug discovery and delivery of novel therapeutic agents for rare disorders of the cardiopulmonary system including pulmonary fibrosis, pulmonary hypertension, and mesothelioma, a rare form of lung cancer associated with asbestos exposure. Dr. Gupta has published 45 journal articles and book chapters in his research field.

• 1. IntroductionPart I – Foundations of Inhaled Drug Product Development2. Dosimetry in Inhaled Product Development3. Inhalation Safety Studies4. Pulmonary Drug Disposition5. Pharmacokinetic-Pharmacodynamic Relationships in the LungPart II – Development of Inhaled Products6. Drug Discovery and Drug Development7. Influence of the Inhalation Delivery Device8. Pre-Clinical Studies9. Uses and Limitations of Animal Models10. Regulatory AspectsPart III – Practical Inhaled Drug Product Development11. Excipient Selection12. Excipient Safety and Toxicological Profile & Functional Excipients13. Medicine Compliance14. Device Development15. Packaging and DistributionPart IV – Conclusions16. The Current Status of Inhaled Drug Product Development

Dr. Vivek Gupta received his Ph.D. in pharmaceutical sciences from Texas Tech University Health Sciences Center, Amarillo, TX. He is currently an assistant professor of industrial pharmacy and pharmaceutics at St. John’s University in New York City. He has more than 10 years of experience in formulation design for novel drug delivery systems for non-invasive delivery of therapeutics, pharmacokinetic and pharmacodynamic characterization of delivery systems for enhanced lung accumulation and bioavailability. Dr. Vivek Gupta’s current research is focused on drug discovery and delivery of novel therapeutic agents for rare disorders of the cardiopulmonary system including pulmonary fibrosis, pulmonary hypertension, and mesothelioma, a rare form of lung cancer associated with asbestos exposure. Dr. Gupta has published 45 journal articles and book chapters in his research field.

• 1. IntroductionPart I – Foundations of Inhaled Drug Product Development2. Dosimetry in Inhaled Product Development3. Inhalation Safety Studies4. Pulmonary Drug Disposition5. Pharmacokinetic-Pharmacodynamic Relationships in the LungPart II – Development of Inhaled Products6. Drug Discovery and Drug Development7. Influence of the Inhalation Delivery Device8. Pre-Clinical Studies9. Uses and Limitations of Animal Models10. Regulatory AspectsPart III – Practical Inhaled Drug Product Development11. Excipient Selection12. Excipient Safety and Toxicological Profile & Functional Excipients13. Medicine Compliance14. Device Development15. Packaging and DistributionPart IV – Conclusions16. The Current Status of Inhaled Drug Product Development

Dr. Vivek Gupta received his Ph.D. in pharmaceutical sciences from Texas Tech University Health Sciences Center, Amarillo, TX. He is currently an assistant professor of industrial pharmacy and pharmaceutics at St. John’s University in New York City. He has more than 10 years of experience in formulation design for novel drug delivery systems for non-invasive delivery of therapeutics, pharmacokinetic and pharmacodynamic characterization of delivery systems for enhanced lung accumulation and bioavailability. Dr. Vivek Gupta’s current research is focused on drug discovery and delivery of novel therapeutic agents for rare disorders of the cardiopulmonary system including pulmonary fibrosis, pulmonary hypertension, and mesothelioma, a rare form of lung cancer associated with asbestos exposure. Dr. Gupta has published 45 journal articles and book chapters in his research field.

• 1. IntroductionPart I – Foundations of Inhaled Drug Product Development2. Dosimetry in Inhaled Product Development3. Inhalation Safety Studies4. Pulmonary Drug Disposition5. Pharmacokinetic-Pharmacodynamic Relationships in the LungPart II – Development of Inhaled Products6. Drug Discovery and Drug Development7. Influence of the Inhalation Delivery Device8. Pre-Clinical Studies9. Uses and Limitations of Animal Models10. Regulatory AspectsPart III – Practical Inhaled Drug Product Development11. Excipient Selection12. Excipient Safety and Toxicological Profile & Functional Excipients13. Medicine Compliance14. Device Development15. Packaging and DistributionPart IV – Conclusions16. The Current Status of Inhaled Drug Product Development